Judith M. Boer

7.2k total citations · 2 hit papers
94 papers, 4.7k citations indexed

About

Judith M. Boer is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Judith M. Boer has authored 94 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 42 papers in Public Health, Environmental and Occupational Health and 28 papers in Hematology. Recurrent topics in Judith M. Boer's work include Acute Lymphoblastic Leukemia research (42 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Gene expression and cancer classification (14 papers). Judith M. Boer is often cited by papers focused on Acute Lymphoblastic Leukemia research (42 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Gene expression and cancer classification (14 papers). Judith M. Boer collaborates with scholars based in Netherlands, Germany and United States. Judith M. Boer's co-authors include Renée X. de Menezes, Gert‐Jan B. van Ommen, H. Berna Beverloo, Johan T. den Dunnen, Peter A.C. ’t Hoen, Gerard C. Grosveld, Peter J.M. Valk, Roel G.W. Verhaak, Claudia Erpelinck-Verschueren and Ruud Delwel and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Judith M. Boer

89 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia

2004 997 citations Judith M. Boer, H. Berna Beverloo et al. profile →
Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms

2008 617 citations Renée X. de Menezes, Judith M. Boer et al. profile →

Peers

Countries citing papers authored by Judith M. Boer

Since Specialization

Citations

This map shows the geographic impact of Judith M. Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith M. Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith M. Boer more than expected).

Fields of papers citing papers by Judith M. Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith M. Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith M. Boer. The network helps show where Judith M. Boer may publish in the future.

Co-authorship network of co-authors of Judith M. Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Judith M. Boer. A scholar is included among the top collaborators of Judith M. Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith M. Boer. Judith M. Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia 2025 ·HemaSphere ·(unknown), (unknown), (unknown), Aurélie Boeree, Cesca van de Ven, (unknown), Edwin Sonneveld, Judith M. Boer, Monique L. den Boer	2
2	From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents 2025 ·PubMed ·Sarah K. Tasian, Judith M. Boer, Monique L. den Boer	0
3	IGH rearrangements in Down syndrome acute lymphoblastic leukemia 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Aurélie Boeree, Edwin Sonneveld, Anthony V. Moorman, (unknown), Rosemary Sutton, H. Berna Beverloo, Rob Pieters, C. Michel Zwaan, Monique L. den Boer, Judith M. Boer	1
4	IKZF1 in acute lymphoblastic leukemia: the rise before the fall? 2024 ·Leukemia & lymphoma ·(unknown), Judith M. Boer, Frank N. van Leeuwen, Rob Pieters, Monique L. den Boer	3
5	Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience 2024 ·HemaSphere ·Judith M. Boer, (unknown), Aurélie Boeree, Karin P.S. Langenberg, Jan Köster, Marco J. Koudijs, Jayne Y. Hehir‐Kwa, Stefan Nierkens, Corinne Rossi, Jan J. Molenaar, Bianca F. Goemans, Monique L. den Boer, C. Michel Zwaan	0
6	ABL-Class Fusion Gene Induced Pediatric CML Presenting As ALL 2024 ·Blood ·Peter M. Hoogerbrugge, (unknown), Judith M. Boer, (unknown), Edwin Sonneveld, Anja W. M. de Jong, Stefan Nierkens, Vincent H. J. van der Velden, Arjan Buijs, Monique L. den Boer	1
7	Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Aurélie Boeree, Edwin Sonneveld, Anthony V. Moorman, (unknown), Rosemary Sutton, H. Berna Beverloo, Rob Pieters, C. Michel Zwaan, Monique L. den Boer, Judith M. Boer	2
8	Secondary Lesions and Sensitivity to Signaling Inhibitors of Pediatric iAMP21 B-Cell Precursor Acute Lymphoblastic Leukemia 2023 ·Blood ·(unknown), (unknown), (unknown), Aurélie Boeree, Cesca van de Ven, Gabriele Escherich, Edwin Sonneveld, Judith M. Boer, Monique L. den Boer	1
9	Integrating copy number data of 64 iAMP21 BCP-ALL patients narrows the common region of amplification to 1.57 Mb 2023 ·Frontiers in Oncology ·(unknown), (unknown), Aurélie Boeree, Edwin Sonneveld, Gabriele Escherich, Monique L. den Boer, Judith M. Boer	3
10	Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement 2022 ·Cancers ·(unknown), Laura Padilla, (unknown), Judith M. Boer, Melanie M. Hagleitner, Birgit Burkhardt, (unknown), Andishe Attarbaschi, Jaime Verdú‐Amorós, Marta Pillon, (unknown), Edita Kabíčková, Aks Chiang, Rejin Kebudi, Karin Mellgren, Jelena Lazić, Janez Jazbec, Jules P.P. Meijerink, Auke Beishuizen, Jan Loeffen	6
11	Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia 2019 ·Scientific Reports ·Elisabeth M. P. Steeghs, Judith M. Boer, (unknown), Aurélie Boeree, Válerie de Haas, Hester A. de Groot‐Kruseman, Martin A. Horstmann, Gabriele Escherich, Rob Pieters, Monique L. den Boer	34
12	High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia 2018 ·Scientific Reports ·Elisabeth M. P. Steeghs, (unknown), (unknown), Judith M. Boer, (unknown), (unknown), Gabriele Escherich, Válerie de Haas, Hester A. de Groot‐Kruseman, Rob Pieters, Monique L. den Boer	11
13	Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome 2017 ·The Journal of Experimental Medicine ·Matthew T. Witkowski, Yifang Hu, Kathryn G. Roberts, Judith M. Boer, Mark McKenzie, (unknown), (unknown), Cédric S. Tremblay, Margherita Ghisi, Tracy A. Willson, Martin A. Horstmann, Iannis Aifantis, Luisa Cimmino, Seth Frietze, Monique L. den Boer, Charles G. Mullighan, Gordon K. Smyth, Ross A. Dickins	22
14	Analysing multiple types of molecular profiles simultaneously: connecting the needles in the haystack 2016 ·BMC Bioinformatics ·Renée X. de Menezes, Leila Mohammadi, Jelle J. Goeman, Judith M. Boer	4
15	A Novel and Fast Normalization Method for High-Density Arrays 2012 ·Statistical Applications in Genetics and Molecular Biology ·Maarten van Iterson, Floor A.M. Duijkers, Jules P.P. Meijerink, Pieter Admiraal, Gert‐Jan B. van Ommen, Judith M. Boer, Max M. van Noesel, Renée X. de Menezes	2
16	Chromosomal Instability in MYH - and APC -Mutant Adenomatous Polyps 2006 ·Cancer Research ·Joana Cardoso, (unknown), Renée X. de Menezes, Monique E. van Leerdam, Carla Rosenberg, Gabriela Möslein, Julian R. Sampson, Hans Morreau, Judith M. Boer, Riccardo Fodde	45
17	GeneHopper: a web-based search engine to link gene-expression platforms through GenBank accession numbers 2003 ·Genome biology ·(unknown), (unknown), Gert‐Jan B. van Ommen, Johan T. den Dunnen, Judith M. Boer	11
18	Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31,500-Element cDNA Array 2001 ·Genome Research ·Judith M. Boer, Wolfgang Huber, Holger Sültmann, (unknown), Anja von Heydebreck, Stefan A. Haas, Bernhard Korn, Bastian Gunawan, Andreas Vente, L. Füzesi, Martin Vingron, Annemarie Poustka	157
19	Processing and quality control of DNA array hybridization data 2000 ·Bioinformatics ·Tim Beißbarth, Kurt Fellenberg, Benedikt Brors, (unknown), Judith M. Boer, Nicole C. Hauser, Marcel Scheideler, Jörg D. Hoheisel, G. Schütz, Annemarie Poustka, Martin Vingron	118
20	The Nucleoporin CAN/Nup214 Binds to both the Cytoplasmic and the Nucleoplasmic Sides of the Nuclear Pore Complex in Overexpressing Cells 1997 ·Experimental Cell Research ·Judith M. Boer, Jan M. A. van Deursen, Huib J. E. Croes, Jack Fransen, Gerard C. Grosveld	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact